nodes	percent_of_prediction	percent_of_DWPC	metapath
Tetrabenazine—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.183	0.346	CbGbCtD
Tetrabenazine—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.183	0.346	CbGbCtD
Tetrabenazine—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.163	0.308	CbGbCtD
Tetrabenazine—Epigastric pain—Aminophylline—chronic obstructive pulmonary disease	0.0106	0.0291	CcSEcCtD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00832	0.0846	CbGpPWpGaD
Tetrabenazine—Donepezil—HTR2A—chronic obstructive pulmonary disease	0.0082	1	CrCbGaD
Tetrabenazine—Epigastric pain—Salbutamol—chronic obstructive pulmonary disease	0.00762	0.0209	CcSEcCtD
Tetrabenazine—SLC18A2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00679	0.069	CbGpPWpGaD
Tetrabenazine—CBR1—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00489	0.0497	CbGpPWpGaD
Tetrabenazine—Memory impairment—Montelukast—chronic obstructive pulmonary disease	0.00487	0.0134	CcSEcCtD
Tetrabenazine—Depression—Roflumilast—chronic obstructive pulmonary disease	0.00429	0.0118	CcSEcCtD
Tetrabenazine—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00416	0.0114	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA5—chronic obstructive pulmonary disease	0.00398	0.0405	CbGpPWpGaD
Tetrabenazine—Menstruation irregular—Prednisolone—chronic obstructive pulmonary disease	0.00382	0.0105	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00379	0.0385	CbGpPWpGaD
Tetrabenazine—Cardiac disorder—Roflumilast—chronic obstructive pulmonary disease	0.00358	0.00984	CcSEcCtD
Tetrabenazine—CBR1—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00356	0.0361	CbGpPWpGaD
Tetrabenazine—Irritability—Aminophylline—chronic obstructive pulmonary disease	0.00355	0.00976	CcSEcCtD
Tetrabenazine—Abdominal pain upper—Aminophylline—chronic obstructive pulmonary disease	0.0034	0.00934	CcSEcCtD
Tetrabenazine—Mental disorder—Roflumilast—chronic obstructive pulmonary disease	0.00338	0.00929	CcSEcCtD
Tetrabenazine—Tension—Roflumilast—chronic obstructive pulmonary disease	0.0033	0.00906	CcSEcCtD
Tetrabenazine—Sleep disorder—Arformoterol—chronic obstructive pulmonary disease	0.00327	0.00899	CcSEcCtD
Tetrabenazine—Sleep disorder—Formoterol—chronic obstructive pulmonary disease	0.00327	0.00899	CcSEcCtD
Tetrabenazine—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00326	0.00897	CcSEcCtD
Tetrabenazine—DRD2—Nicotine Activity on Dopaminergic Neurons—CHRNA3—chronic obstructive pulmonary disease	0.00325	0.033	CbGpPWpGaD
Tetrabenazine—Sleep disorder—Montelukast—chronic obstructive pulmonary disease	0.0032	0.0088	CcSEcCtD
Tetrabenazine—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00315	0.00865	CcSEcCtD
Tetrabenazine—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.0031	0.00852	CcSEcCtD
Tetrabenazine—Dysphagia—Tiotropium—chronic obstructive pulmonary disease	0.00303	0.00833	CcSEcCtD
Tetrabenazine—Anxiety—Roflumilast—chronic obstructive pulmonary disease	0.00285	0.00783	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Roflumilast—chronic obstructive pulmonary disease	0.00284	0.0078	CcSEcCtD
Tetrabenazine—Dysuria—Tiotropium—chronic obstructive pulmonary disease	0.00284	0.00779	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Tiotropium—chronic obstructive pulmonary disease	0.00282	0.00774	CcSEcCtD
Tetrabenazine—Menstruation irregular—Prednisone—chronic obstructive pulmonary disease	0.00277	0.00762	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.0027	0.0274	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Roflumilast—chronic obstructive pulmonary disease	0.00269	0.00739	CcSEcCtD
Tetrabenazine—Skin disorder—Roflumilast—chronic obstructive pulmonary disease	0.00266	0.00732	CcSEcCtD
Tetrabenazine—Irritability—Montelukast—chronic obstructive pulmonary disease	0.00265	0.00727	CcSEcCtD
Tetrabenazine—Irritability—Salbutamol—chronic obstructive pulmonary disease	0.00255	0.00701	CcSEcCtD
Tetrabenazine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00251	0.00691	CcSEcCtD
Tetrabenazine—Insomnia—Roflumilast—chronic obstructive pulmonary disease	0.00248	0.00681	CcSEcCtD
Tetrabenazine—SLC18A2—Synaptic Vesicle Pathway—SLC6A4—chronic obstructive pulmonary disease	0.00248	0.0252	CbGpPWpGaD
Tetrabenazine—CBR1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00247	0.0251	CbGpPWpGaD
Tetrabenazine—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00244	0.00671	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Tiotropium—chronic obstructive pulmonary disease	0.0024	0.00659	CcSEcCtD
Tetrabenazine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00238	0.00655	CcSEcCtD
Tetrabenazine—Urethral disorder—Tiotropium—chronic obstructive pulmonary disease	0.00238	0.00654	CcSEcCtD
Tetrabenazine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.00236	0.00649	CcSEcCtD
Tetrabenazine—Bronchitis—Formoterol—chronic obstructive pulmonary disease	0.00235	0.00647	CcSEcCtD
Tetrabenazine—Bronchitis—Arformoterol—chronic obstructive pulmonary disease	0.00235	0.00647	CcSEcCtD
Tetrabenazine—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00234	0.00644	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00234	0.0238	CbGpPWpGaD
Tetrabenazine—Bronchitis—Montelukast—chronic obstructive pulmonary disease	0.00231	0.00633	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.0023	0.0233	CbGpPWpGaD
Tetrabenazine—Upper respiratory tract infection—Formoterol—chronic obstructive pulmonary disease	0.00227	0.00625	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Arformoterol—chronic obstructive pulmonary disease	0.00227	0.00625	CcSEcCtD
Tetrabenazine—Eye disorder—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00623	CcSEcCtD
Tetrabenazine—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00226	0.00621	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00612	CcSEcCtD
Tetrabenazine—Bronchitis—Salbutamol—chronic obstructive pulmonary disease	0.00222	0.00611	CcSEcCtD
Tetrabenazine—Angiopathy—Tiotropium—chronic obstructive pulmonary disease	0.0022	0.00605	CcSEcCtD
Tetrabenazine—Tension—Aminophylline—chronic obstructive pulmonary disease	0.0022	0.00604	CcSEcCtD
Tetrabenazine—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00218	0.00598	CcSEcCtD
Tetrabenazine—Dysuria—Salbutamol—chronic obstructive pulmonary disease	0.00216	0.00594	CcSEcCtD
Tetrabenazine—Upper respiratory tract infection—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.0059	CcSEcCtD
Tetrabenazine—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00214	0.00587	CcSEcCtD
Tetrabenazine—Mental disorder—Tiotropium—chronic obstructive pulmonary disease	0.00213	0.00584	CcSEcCtD
Tetrabenazine—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.0021	0.00577	CcSEcCtD
Tetrabenazine—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00206	0.00566	CcSEcCtD
Tetrabenazine—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00206	0.00566	CcSEcCtD
Tetrabenazine—Sweating—Salbutamol—chronic obstructive pulmonary disease	0.00198	0.00543	CcSEcCtD
Tetrabenazine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00197	0.00541	CcSEcCtD
Tetrabenazine—Memory impairment—Prednisone—chronic obstructive pulmonary disease	0.00196	0.00537	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Arformoterol—chronic obstructive pulmonary disease	0.00193	0.00531	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Formoterol—chronic obstructive pulmonary disease	0.00193	0.00531	CcSEcCtD
Tetrabenazine—Urethral disorder—Arformoterol—chronic obstructive pulmonary disease	0.00192	0.00528	CcSEcCtD
Tetrabenazine—Urethral disorder—Formoterol—chronic obstructive pulmonary disease	0.00192	0.00528	CcSEcCtD
Tetrabenazine—Ecchymosis—Prednisolone—chronic obstructive pulmonary disease	0.00191	0.00525	CcSEcCtD
Tetrabenazine—Anxiety—Aminophylline—chronic obstructive pulmonary disease	0.0019	0.00522	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Montelukast—chronic obstructive pulmonary disease	0.00189	0.00521	CcSEcCtD
Tetrabenazine—Urethral disorder—Montelukast—chronic obstructive pulmonary disease	0.00188	0.00517	CcSEcCtD
Tetrabenazine—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00188	0.00515	CcSEcCtD
Tetrabenazine—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.00183	0.00502	CcSEcCtD
Tetrabenazine—Cardiac disorder—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00499	CcSEcCtD
Tetrabenazine—Cardiac disorder—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00499	CcSEcCtD
Tetrabenazine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00181	0.00498	CcSEcCtD
Tetrabenazine—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.00181	0.00498	CcSEcCtD
Tetrabenazine—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.00179	0.00493	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.00179	0.00491	CcSEcCtD
Tetrabenazine—Cardiac disorder—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00489	CcSEcCtD
Tetrabenazine—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.00176	0.00483	CcSEcCtD
Tetrabenazine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.00479	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00173	0.0176	CbGpPWpGaD
Tetrabenazine—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00172	0.00472	CcSEcCtD
Tetrabenazine—Cardiac disorder—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00472	CcSEcCtD
Tetrabenazine—Mental disorder—Arformoterol—chronic obstructive pulmonary disease	0.00172	0.00471	CcSEcCtD
Tetrabenazine—Mental disorder—Formoterol—chronic obstructive pulmonary disease	0.00172	0.00471	CcSEcCtD
Tetrabenazine—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.00171	0.00469	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00171	0.0174	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.00169	0.00465	CcSEcCtD
Tetrabenazine—Mental disorder—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00462	CcSEcCtD
Tetrabenazine—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.00168	0.00461	CcSEcCtD
Tetrabenazine—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.0046	CcSEcCtD
Tetrabenazine—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00167	0.0046	CcSEcCtD
Tetrabenazine—Tension—Formoterol—chronic obstructive pulmonary disease	0.00167	0.0046	CcSEcCtD
Tetrabenazine—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00166	0.00455	CcSEcCtD
Tetrabenazine—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00166	0.00455	CcSEcCtD
Tetrabenazine—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00165	0.00454	CcSEcCtD
Tetrabenazine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00163	0.00447	CcSEcCtD
Tetrabenazine—Mental disorder—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00445	CcSEcCtD
Tetrabenazine—Tremor—Formoterol—chronic obstructive pulmonary disease	0.0016	0.00439	CcSEcCtD
Tetrabenazine—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.0016	0.00439	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.00159	0.0162	CbGpPWpGaD
Tetrabenazine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00159	0.00437	CcSEcCtD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.00158	0.0161	CbGpPWpGaD
Tetrabenazine—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00158	0.00434	CcSEcCtD
Tetrabenazine—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.00157	0.00431	CcSEcCtD
Tetrabenazine—Agitation—Formoterol—chronic obstructive pulmonary disease	0.00157	0.00431	CcSEcCtD
Tetrabenazine—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00156	0.0043	CcSEcCtD
Tetrabenazine—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00156	0.0043	CcSEcCtD
Tetrabenazine—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00156	0.00428	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.00154	0.0157	CbGpPWpGaD
Tetrabenazine—Agitation—Montelukast—chronic obstructive pulmonary disease	0.00153	0.00422	CcSEcCtD
Tetrabenazine—Osteoarthritis—Prednisolone—chronic obstructive pulmonary disease	0.00153	0.00421	CcSEcCtD
Tetrabenazine—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00151	0.00414	CcSEcCtD
Tetrabenazine—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.00148	0.00407	CcSEcCtD
Tetrabenazine—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.00405	CcSEcCtD
Tetrabenazine—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00397	CcSEcCtD
Tetrabenazine—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00397	CcSEcCtD
Tetrabenazine—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00145	0.00397	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00144	0.00396	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00144	0.00396	CcSEcCtD
Tetrabenazine—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00142	0.0039	CcSEcCtD
Tetrabenazine—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00142	0.0039	CcSEcCtD
Tetrabenazine—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00389	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00141	0.00388	CcSEcCtD
Tetrabenazine—Ecchymosis—Prednisone—chronic obstructive pulmonary disease	0.00139	0.00381	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00137	0.0139	CbGpPWpGaD
Tetrabenazine—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00375	CcSEcCtD
Tetrabenazine—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00375	CcSEcCtD
Tetrabenazine—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00375	CcSEcCtD
Tetrabenazine—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00371	CcSEcCtD
Tetrabenazine—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00371	CcSEcCtD
Tetrabenazine—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00368	CcSEcCtD
Tetrabenazine—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00134	0.00367	CcSEcCtD
Tetrabenazine—CYP2D6—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.00132	0.0135	CbGpPWpGaD
Tetrabenazine—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00364	CcSEcCtD
Tetrabenazine—DRD2—Monoamine GPCRs—ADRB2—chronic obstructive pulmonary disease	0.00132	0.0134	CbGpPWpGaD
Tetrabenazine—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.0013	0.00357	CcSEcCtD
Tetrabenazine—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.0013	0.00357	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.0013	0.0132	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00129	0.00354	CcSEcCtD
Tetrabenazine—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00351	CcSEcCtD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00127	0.0129	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00349	CcSEcCtD
Tetrabenazine—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00126	0.00346	CcSEcCtD
Tetrabenazine—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00126	0.00346	CcSEcCtD
Tetrabenazine—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00344	CcSEcCtD
Tetrabenazine—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00124	0.00341	CcSEcCtD
Tetrabenazine—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.00341	CcSEcCtD
Tetrabenazine—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00124	0.0034	CcSEcCtD
Tetrabenazine—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00124	0.0034	CcSEcCtD
Tetrabenazine—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00339	CcSEcCtD
Tetrabenazine—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00123	0.00337	CcSEcCtD
Tetrabenazine—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00333	CcSEcCtD
Tetrabenazine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00121	0.00332	CcSEcCtD
Tetrabenazine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0012	0.0033	CcSEcCtD
Tetrabenazine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.0033	CcSEcCtD
Tetrabenazine—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00327	CcSEcCtD
Tetrabenazine—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00119	0.00327	CcSEcCtD
Tetrabenazine—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00119	0.00327	CcSEcCtD
Tetrabenazine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00323	CcSEcCtD
Tetrabenazine—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00322	CcSEcCtD
Tetrabenazine—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00321	CcSEcCtD
Tetrabenazine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.00319	CcSEcCtD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.00116	0.0118	CbGpPWpGaD
Tetrabenazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.00115	0.0117	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00315	CcSEcCtD
Tetrabenazine—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00315	CcSEcCtD
Tetrabenazine—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00315	CcSEcCtD
Tetrabenazine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00314	CcSEcCtD
Tetrabenazine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00313	CcSEcCtD
Tetrabenazine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00311	CcSEcCtD
Tetrabenazine—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00309	CcSEcCtD
Tetrabenazine—SLC18A2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00112	0.0114	CbGpPWpGaD
Tetrabenazine—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00111	0.00306	CcSEcCtD
Tetrabenazine—DRD2—Amine ligand-binding receptors—ADRB2—chronic obstructive pulmonary disease	0.00111	0.0113	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00302	CcSEcCtD
Tetrabenazine—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00302	CcSEcCtD
Tetrabenazine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00301	CcSEcCtD
Tetrabenazine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00109	0.00298	CcSEcCtD
Tetrabenazine—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00298	CcSEcCtD
Tetrabenazine—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00297	CcSEcCtD
Tetrabenazine—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.00108	0.00297	CcSEcCtD
Tetrabenazine—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00296	CcSEcCtD
Tetrabenazine—SLC18A2—Dopaminergic Neurogenesis—TGFB1—chronic obstructive pulmonary disease	0.00107	0.0109	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00106	0.0108	CbGpPWpGaD
Tetrabenazine—Irritability—Prednisone—chronic obstructive pulmonary disease	0.00106	0.00292	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00105	0.0107	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00285	CcSEcCtD
Tetrabenazine—DRD2—Monoamine GPCRs—HTR2A—chronic obstructive pulmonary disease	0.00103	0.0105	CbGpPWpGaD
Tetrabenazine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00102	0.00281	CcSEcCtD
Tetrabenazine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000999	0.00274	CcSEcCtD
Tetrabenazine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000999	0.00274	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—CYP1A2—chronic obstructive pulmonary disease	0.000984	0.01	CbGpPWpGaD
Tetrabenazine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000978	0.00269	CcSEcCtD
Tetrabenazine—CYP2D6—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	0.000962	0.00978	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000952	0.00262	CcSEcCtD
Tetrabenazine—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000952	0.00262	CcSEcCtD
Tetrabenazine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000943	0.00259	CcSEcCtD
Tetrabenazine—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000933	0.00256	CcSEcCtD
Tetrabenazine—CYP2D6—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000925	0.00941	CbGpPWpGaD
Tetrabenazine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00092	0.00253	CcSEcCtD
Tetrabenazine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00092	0.00253	CcSEcCtD
Tetrabenazine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000901	0.00248	CcSEcCtD
Tetrabenazine—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000899	0.00247	CcSEcCtD
Tetrabenazine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00243	CcSEcCtD
Tetrabenazine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00243	CcSEcCtD
Tetrabenazine—Headache—Formoterol—chronic obstructive pulmonary disease	0.000872	0.0024	CcSEcCtD
Tetrabenazine—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.0024	CcSEcCtD
Tetrabenazine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000869	0.00239	CcSEcCtD
Tetrabenazine—DRD2—Amine ligand-binding receptors—HTR2A—chronic obstructive pulmonary disease	0.000867	0.00881	CbGpPWpGaD
Tetrabenazine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000867	0.00238	CcSEcCtD
Tetrabenazine—SLC18A2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.000857	0.00871	CbGpPWpGaD
Tetrabenazine—Depression—Prednisone—chronic obstructive pulmonary disease	0.000856	0.00235	CcSEcCtD
Tetrabenazine—Headache—Montelukast—chronic obstructive pulmonary disease	0.000854	0.00235	CcSEcCtD
Tetrabenazine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.0023	CcSEcCtD
Tetrabenazine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000827	0.00227	CcSEcCtD
Tetrabenazine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000827	0.00227	CcSEcCtD
Tetrabenazine—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00226	CcSEcCtD
Tetrabenazine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00081	0.00222	CcSEcCtD
Tetrabenazine—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000785	0.00216	CcSEcCtD
Tetrabenazine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000781	0.00214	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—EDN1—chronic obstructive pulmonary disease	0.000763	0.00775	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000759	0.00772	CbGpPWpGaD
Tetrabenazine—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000729	0.002	CcSEcCtD
Tetrabenazine—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.00072	0.00198	CcSEcCtD
Tetrabenazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000715	0.00727	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000705	0.00717	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000699	0.00711	CbGpPWpGaD
Tetrabenazine—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000699	0.00192	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GC—chronic obstructive pulmonary disease	0.000686	0.00697	CbGpPWpGaD
Tetrabenazine—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000682	0.00187	CcSEcCtD
Tetrabenazine—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000675	0.00186	CcSEcCtD
Tetrabenazine—CBR1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000649	0.00659	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000638	0.00648	CbGpPWpGaD
Tetrabenazine—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000621	0.00171	CcSEcCtD
Tetrabenazine—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000617	0.00169	CcSEcCtD
Tetrabenazine—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000569	0.00156	CcSEcCtD
Tetrabenazine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000567	0.00156	CcSEcCtD
Tetrabenazine—CYP2D6—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000562	0.00572	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.00055	0.00559	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000543	0.00552	CbGpPWpGaD
Tetrabenazine—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000537	0.00148	CcSEcCtD
Tetrabenazine—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000532	0.00146	CcSEcCtD
Tetrabenazine—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000529	0.00145	CcSEcCtD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000508	0.00517	CbGpPWpGaD
Tetrabenazine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000498	0.00137	CcSEcCtD
Tetrabenazine—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000495	0.00136	CcSEcCtD
Tetrabenazine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000476	0.00131	CcSEcCtD
Tetrabenazine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000472	0.0013	CcSEcCtD
Tetrabenazine—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000472	0.0013	CcSEcCtD
Tetrabenazine—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000468	0.00129	CcSEcCtD
Tetrabenazine—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000451	0.00124	CcSEcCtD
Tetrabenazine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000448	0.00123	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000446	0.00453	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.000437	0.00445	CbGpPWpGaD
Tetrabenazine—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000433	0.00119	CcSEcCtD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—CXCR2—chronic obstructive pulmonary disease	0.000406	0.00413	CbGpPWpGaD
Tetrabenazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.0004	0.00406	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000396	0.00403	CbGpPWpGaD
Tetrabenazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000394	0.00401	CbGpPWpGaD
Tetrabenazine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000393	0.00108	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000375	0.00381	CbGpPWpGaD
Tetrabenazine—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000375	0.00103	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00037	0.00377	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000364	0.0037	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000362	0.00368	CbGpPWpGaD
Tetrabenazine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000995	CcSEcCtD
Tetrabenazine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000957	CcSEcCtD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000348	0.00354	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	0.000345	0.00351	CbGpPWpGaD
Tetrabenazine—Headache—Prednisone—chronic obstructive pulmonary disease	0.000343	0.000943	CcSEcCtD
Tetrabenazine—CBR1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000338	0.00344	CbGpPWpGaD
Tetrabenazine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000325	0.000894	CcSEcCtD
Tetrabenazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000324	0.00329	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000311	0.00317	CbGpPWpGaD
Tetrabenazine—SLC18A2—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000301	0.00306	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000285	0.0029	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000282	0.00286	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000265	0.00269	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00026	0.00264	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000256	0.0026	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000255	0.00259	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.000255	0.00259	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000239	0.00243	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000237	0.00241	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000234	0.00237	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000226	0.0023	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000226	0.0023	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.000218	0.00222	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000217	0.00221	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000211	0.00214	CbGpPWpGaD
Tetrabenazine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000199	0.00202	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000198	0.00201	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000195	0.00198	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000195	0.00198	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000186	0.00189	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000181	0.00184	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000179	0.00182	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000177	0.0018	CbGpPWpGaD
Tetrabenazine—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000172	0.00175	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000171	0.00173	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00017	0.00172	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000169	0.00171	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000166	0.00169	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—ALB—chronic obstructive pulmonary disease	0.000154	0.00156	CbGpPWpGaD
Tetrabenazine—SLC18A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.000153	0.00155	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.00015	0.00152	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000148	0.00151	CbGpPWpGaD
Tetrabenazine—CBR1—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000147	0.0015	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	0.000138	0.00141	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000136	0.00138	CbGpPWpGaD
Tetrabenazine—DRD2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000133	0.00135	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000131	0.00134	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.00013	0.00132	CbGpPWpGaD
Tetrabenazine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000105	0.00107	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	9.96e-05	0.00101	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	9.39e-05	0.000954	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.22e-05	0.000937	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	9.17e-05	0.000932	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	8.92e-05	0.000907	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	8.53e-05	0.000867	CbGpPWpGaD
Tetrabenazine—DRD2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.44e-05	0.000858	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	8.39e-05	0.000853	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	8.29e-05	0.000843	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	8.03e-05	0.000816	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	8.02e-05	0.000816	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	7.62e-05	0.000775	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	7.34e-05	0.000746	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	6.67e-05	0.000678	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	5.87e-05	0.000597	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—KL—chronic obstructive pulmonary disease	5.46e-05	0.000555	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	5.04e-05	0.000512	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.87e-05	0.000495	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	4.82e-05	0.00049	CbGpPWpGaD
Tetrabenazine—DRD2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	4.53e-05	0.000461	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	4.5e-05	0.000458	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	4.4e-05	0.000447	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	4.12e-05	0.000419	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	4.09e-05	0.000416	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.05e-05	0.000412	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	3.94e-05	0.0004	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	3.66e-05	0.000372	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.38e-05	0.000343	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.33e-05	0.000339	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.1e-05	0.000315	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	3.01e-05	0.000306	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.94e-05	0.000299	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	2.87e-05	0.000292	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	2.74e-05	0.000279	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	2.43e-05	0.000247	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	2.31e-05	0.000235	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	2.2e-05	0.000224	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2e-05	0.000203	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.98e-05	0.000201	CbGpPWpGaD
Tetrabenazine—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.91e-05	0.000194	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.81e-05	0.000184	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.78e-05	0.000181	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1.49e-05	0.000152	CbGpPWpGaD
Tetrabenazine—DRD2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.37e-05	0.000139	CbGpPWpGaD
